Nick S. Laursen

Arhus, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Curbing Autoimmunity: A New Fab Fragment Targeting CD40-CD40L Halts B-Cell Activation and Differentiation.

Curbing Autoimmunity: A New Fab Fragment Targeting CD40-CD40L Halts B-Cell Activation and Differentiation.

Journal: European journal of immunology

Published: July 23, 2025

Differences in complement activation of serum-resistant and serum-sensitive Klebsiella pneumoniae isolates.

Differences in complement activation of serum-resistant and serum-sensitive Klebsiella pneumoniae isolates.

Journal: Molecular immunology

Published: February 13, 2025

Pharmacological blocking of microfibrillar-associated protein 4 reduces retinal neoangiogenesis and vascular leakage.

Pharmacological blocking of microfibrillar-associated protein 4 reduces retinal neoangiogenesis and vascular leakage.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: August 23, 2024

Transition metal transporting P-type ATPases: terminal metal-binding domains serve as sensors for autoinhibitory tails.

Transition metal transporting P-type ATPases: terminal metal-binding domains serve as sensors for autoinhibitory tails.

Journal: The FEBS journal

Published: April 18, 2024

Development of an immunoassay for quantification of soluble human CD40L (CD154) in plasma and serum samples.

Development of an immunoassay for quantification of soluble human CD40L (CD154) in plasma and serum samples.

Journal: Journal of immunological methods

Published: February 01, 2024

Correction: A potent complement factor C3-specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complement.

Correction: A potent complement factor C3-specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complement.

Journal: The Journal of biological chemistry

Published: February 05, 2023

Bispecific Complement Engagers for Targeted Complement Activation.

Bispecific Complement Engagers for Targeted Complement Activation.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: December 30, 2022

Nanobody-mediated complement activation to kill HIV-infected cells.

Nanobody-mediated complement activation to kill HIV-infected cells.

Journal: EMBO molecular medicine

Published: June 08, 2022

Structural insights into the function-modulating effects of nanobody binding to the integrin receptor αMβ2.

Structural insights into the function-modulating effects of nanobody binding to the integrin receptor αMβ2.

Journal: The Journal of biological chemistry

Published: May 01, 2022

Nanobody-based human antibody formats act as IgE surrogate in hymenoptera venom allergy.

Nanobody-based human antibody formats act as IgE surrogate in hymenoptera venom allergy.

Journal: Allergy

Published: March 31, 2022

Structure-Guided Engineering of a Complement Component C3-Binding Nanobody Improves Specificity and Adds Cofactor Activity.

Structure-Guided Engineering of a Complement Component C3-Binding Nanobody Improves Specificity and Adds Cofactor Activity.

Journal: Frontiers in immunology

Published: February 09, 2022

Purification of Human Complement Component C4 and Sample Preparation for Structural Biology Applications.

Purification of Human Complement Component C4 and Sample Preparation for Structural Biology Applications.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: April 13, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026